Taysha Gene Therapies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TSHA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Jun 24	BuyUS$2,999,999	Paul Manning	Individual	1,333,333	US$2.25
17 Nov 23	BuyUS$163,000	Paul Manning	Individual	100,000	US$1.63
16 Aug 23	BuyUS$14,820,000	Paul Manning	Individual	16,466,667	US$0.90
16 Aug 23	BuyUS$100,000	Phillip Donenberg	Individual	111,111	US$0.90
16 Aug 23	BuyUS$400,000	Sean Nolan	Individual	444,444	US$0.90
16 Aug 23	BuyUS$700,000	Sean Stalfort	Individual	777,778	US$0.90
13 Jul 23	SellUS$60,771	R. Session	Individual	85,872	US$0.71

Insider Trading Volume

Insider Buying: TSHA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TSHA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	24,129	0.012%
Public Companies	7,266,342	3.61%
VC/PE Firms	10,872,503	5.4%
General Public	25,239,791	12.5%
Individual Insiders	27,070,586	13.4%
Hedge Funds	37,243,185	18.5%
Institutions	93,662,852	46.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 213.8%.

Top Shareholders

Top 25 shareholders own 79.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.3%	Paul Manning	24,829,111	US$53.4m	5.67%	no data
9.99%	FMR LLC	20,110,717	US$43.2m	-10.4%	no data
9.26%	Avoro Capital Advisors LLC	18,650,000	US$40.1m	328%	0.5%
9.23%	RTW Investments, LP	18,593,185	US$40.0m	10.1%	0.71%
5.4%	RA Capital Management, L.P.	10,872,503	US$23.4m	-41.1%	0.33%
4.47%	VR Adviser, LLC	9,000,000	US$19.4m	-13.6%	0.99%
3.61%	Astellas Pharma Inc.	7,266,342	US$15.6m	0%	no data
2.94%	The Vanguard Group, Inc.	5,917,414	US$12.7m	-4.49%	no data
2.57%	Morgan Stanley, Investment Banking and Brokerage Investments	5,167,252	US$11.1m	2,310%	no data
1.99%	Baker Bros. Advisors LP	4,004,756	US$8.6m	0%	0.11%
1.84%	Tybourne Capital Management (HK) Ltd.	3,700,000	US$8.0m	0%	1.56%
1.83%	Artal Group S.A.	3,687,548	US$7.9m	0.67%	0.2%
1.66%	Acuta Capital Partners, LLC	3,333,333	US$7.2m	-7.13%	5.75%
1.56%	Millennium Management LLC	3,135,317	US$6.7m	-7.25%	0.01%
1.5%	Octagon Capital Advisors LP	3,030,000	US$6.5m	0%	1.05%
1.29%	BlackRock, Inc.	2,597,303	US$5.6m	-3.78%	no data
1.25%	Polar Capital Holdings Plc	2,518,909	US$5.4m	0%	0.02%
1.15%	Eversept Partners, L.P.	2,325,591	US$5.0m	-38.5%	0.41%
0.96%	Sean Stalfort	1,933,671	US$4.2m	0%	no data
0.89%	Eagle Asset Management, Inc.	1,789,394	US$3.8m	0%	0.02%
0.77%	Cowen Inc,Private Banking and Investment Banking Investments	1,550,000	US$3.3m	0%	0.11%
0.76%	Nolan Capital, Inc.	1,535,545	US$3.3m	0%	no data
0.72%	Point72 Asset Management, L.P.	1,455,638	US$3.1m	-46.8%	0.01%
0.65%	Susquehanna International Group, LLP, Asset Management Arm	1,309,627	US$2.8m	-8.3%	no data
0.55%	T. Rowe Price Group, Inc.	1,099,329	US$2.4m	-10.4%	no data